Trial Summary
What is the purpose of this trial?The aim of this trial is to test components of a digital health outreach intervention to promote uptake of postpartum screening and lifestyle programs for diabetes prevention among patients with gestational diabetes (GDM). The outreach intervention, designed to be interactive and delivered online, includes standard health information plus up to four theory-based components, targeting motivational and logistical barriers to engaging in diabetes preventive care during the postpartum period. The trial leverages the Multiphase Optimization Strategy (MOST) using a randomized factorial study design.
Eligibility Criteria
This trial is for pregnant individuals aged 18 or older with gestational diabetes, who speak English and are in contact with the Kaiser Permanente Northern California's perinatal service. It excludes those currently hospitalized, with pregnancy loss, prior requests to avoid research invites, eating disorders, or pre-pregnancy diabetes.Inclusion Criteria
I am 18 years old or older.
You are currently pregnant and have gestational diabetes.
You have been in touch with the Kaiser Permanente Northern California (KPNC) Regional Perinatal Service Center.
+1 more
Exclusion Criteria
You were diagnosed with diabetes before getting pregnant.
The mother or baby is currently staying in the hospital.
You have a history of an eating disorder.
+2 more
Participant Groups
The study tests a digital health program designed to encourage postpartum screening and lifestyle changes for diabetes prevention. Participants receive standard health info plus up to four additional components like motivational interviewing and action planning using an interactive online platform.
16Treatment groups
Experimental Treatment
Group I: Condition 9Experimental Treatment4 Interventions
Standard health message + TRI + MI+ AP
Group II: Condition 8Experimental Treatment2 Interventions
Standard health message + VA
Group III: Condition 7Experimental Treatment3 Interventions
Standard health message + VA + AP
Group IV: Condition 6Experimental Treatment3 Interventions
Standard health message + VA + MI
Group V: Condition 5Experimental Treatment4 Interventions
Standard health message + VA + MI+ AP
Group VI: Condition 4Experimental Treatment3 Interventions
Standard health message + VA + TRI
Group VII: Condition 3Experimental Treatment4 Interventions
Standard health message + VA + TRI + AP
Group VIII: Condition 2Experimental Treatment4 Interventions
Standard health message + VA + TRI + MI
Group IX: Condition 16Experimental Treatment1 Intervention
Standard health message
Group X: Condition 15Experimental Treatment2 Interventions
Standard health message + AP
Group XI: Condition 14Experimental Treatment2 Interventions
Standard health message + MI
Group XII: Condition 13Experimental Treatment3 Interventions
Standard health message + MI+ AP
Group XIII: Condition 12Experimental Treatment2 Interventions
Standard health message + TRI
Group XIV: Condition 11Experimental Treatment3 Interventions
Standard health message + TRI + AP
Group XV: Condition 10Experimental Treatment3 Interventions
Standard health message + TRI + MI
Group XVI: Condition 1Experimental Treatment5 Interventions
Standard health message + VA + TRI + MI+ AP
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Kaiser Permanente Northern CaliforniaOakland, CA
Loading ...
Who Is Running the Clinical Trial?
University of California, DavisLead Sponsor
Kaiser Foundation Research InstituteCollaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Collaborator